Trial NCT05934097

View at ClinicalTrials.gov 
Org. Study IDs: FT596-102

Last trial update was posted on 2023-07-06

MeSH Interventions

Bendamustine Hydrochloride Cyclophosphamide Doxorubicin Prednisone Rituximab Vincristine

MeSH Conditions

Lymphoma Lymphoma, B-Cell Lymphoma, Large B-Cell, Diffuse Lymphoma, Mantle-Cell

Other Conditions

Diffuse Large B Cell Lymphoma Follicular Lymphoma Mantle Cell Lymphoma Marginal Zone Lymphoma Transformed Indolent Non-Hodgkin's Lymphoma

Stopping Reasons

This study was withdrawn (Sponsor decision).

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID